Novel drugs for patients with renal cell carcinoma
Can atezolizumab succeed where BCG fails in bladder cancer?
KEYNOTE-189: chemo plus pembrolizumab for NSCLC
Paradigm-changing immunotherapy for advanced NSCLC: the PACIFIC and beyond
Changing the standard of care in previously treated metastatic renal cell carcinoma